ArticleFrontiers in cardiovascular medicine2026
Chronic Brucella infection associated with amyloid light chain cardiac amyloidosis: a case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Amyloidosis is a rare group of diseases characterized by extracellular deposition of amyloid fibrils. The most common types are amyloid light chain (AL) and transthyretin (ATTR), while serum amyloid A (AA) type is relatively rare. Infections are often associated with AA amyloidosis, whereas AL amyloidosis typically results from abnormal proliferation of monoclonal plasma cells. However, the relationship between AL amyloidosis and infections remains unclear. Case presentation: We present the case of a 69-year-old male patient with chronic brucellosis complicated by heart failure. Laboratory tests showed significantly elevated myocardial enzymes and N-terminal pro-B type natriuretic peptide. Cardiac echocardiography and cardiac magnetic resonance imaging revealed abnormal myocardial hypertrophy, and the patient showed poor response to myocarditis-targeted treatment. Outcome: Genetic testing for inherited cardiomyopathies ruled out Fabry disease, hereditary hypertrophic cardiomyopathy, and ATTR amyloidosis-associated abnormal genes. Serum immunofixation electrophoresis indicated positivity for lambda light chain. AL cardiac amyloidosis was confirmed by myocardial biopsy. Conclusion: We report a case of chronic Brucella infection and AL-type cardiac amyloidosis, with a high overlap in clinical onset time. However, additional studies are needed to confirm the potential relationship between Brucella infection and AL-type cardiac amyloidosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.